Influence of irradiation on the activity of antioxidant enzymes in lung tissue and lung cancer cells, in different stages of histological maturity Source: Eur Respir J 2001; 18: Suppl. 33, 78s Year: 2001
Influence of overexpression of coagulantic and fibrolytic components in tumor tissues on the prognosis of non-small cell lung cancer Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology Year: 2007
Assessment of lipid peroxidation and antioxidant capacity in pulmonary parenchyma and lung cancer tissue in non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 79s Year: 2004
The influence of brown adipose tissue on the proliferation and chemosensitivity in non-small cell lung cancer cells Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018
Choice of endogenous control for gene expression in nonsmall cell lung cancer Source: Eur Respir J 2005; 26: 1002-1008 Year: 2005
Specific plasmids encoding shRNA molecules directed against growth factor receptors in cell proliferation inhibition and induction phenotype changes relevant to enhancement of anti-tumor immunity. Model of human non-small (NSCLC) and small (SCLC) cell lung cancer lines Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010
Extracts of lung cancer cells reveal antitumour antibodies in sera of patients with lung cancer Source: Eur Respir J 2003; 21: 342-346 Year: 2003
HIF-1α modulation by topoisomerase inhibitors in A549, a non-small cell lung cancer cell line Source: Annual Congress 2007 - Biology in thoracic oncology Year: 2007
The effects of human lung mast cell products on the synthetic functions of lung fibroblasts Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung Year: 2012
Glycolytic phenotype mapping in lung cancer cell lines Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012
Evaluation of promoter hypermethylation in tissue and blood of non-small cell lung cancer patients and association with survival. Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018
Analysis of the prognosis value of the mitochondrial activity in resected non-small cell lung cancer (NSCLC) Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010
Modulation of tumor-microenvironmental factors and cancer growth in co-cultures of fresh human lung tissue and patient-derived cancer cells Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018
LSC Abstract – Transcriptomic profiling of macrophages isolated from human non-small cell lung carcinoma (NSCLC) reveals novel macrophage subsets with distinct tumour response features Source: International Congress 2016 – Lung cancer immunology: latest research Year: 2016
The expression of Ki-67, a marker of proliferative activity, in resected nonsmall cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 478s Year: 2001
Cyclooxygenase(COX)-2 is over-expressed in non small cell lung cancer (NSCLC) and is a potential target for treatment Source: Eur Respir J 2002; 20: Suppl. 38, 400s Year: 2002
Proteinase inhibition regulates the anti-tumor activity of PAI-1 towards lung and prostate cancer cells Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011
A low endothelial cell proliferation fraction, a measurement of ongoing angiogenesis, is associated with poor prognosis in non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 763s Year: 2006
The influence of conventional and targeted chemotherapy on the expression of stem cell markers in lung cancer cell lines Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome Year: 2017
Quantification of telomerase activity is important in predicting prognosis of patients with non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 482s Year: 2005